Related Experiment Video

Updated: Aug 7, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Interferon receptor expression regulates the antiproliferative effects of interferons on cancer cells and solid

T Charis Wagner1, Sharlene Velichko, Steven K Chesney

  • 1Department of Immunology, Berlex Bioscience Inc., Richmond, CA 94804, USA.

International Journal of Cancer
|June 9, 2004
PubMed

Insights

Enhancing Type I Interferon receptor (IFNAR2c) expression in cancer cells increases their sensitivity to Type I Interferon (IFN) therapy, leading to reduced tumor growth and increased apoptosis. This suggests a strategy for improving IFN-based cancer treatments.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Type I interferons (IFN) possess antiproliferative and immunomodulatory properties, making them candidates for cancer therapy.
  • However, IFN efficacy is limited to specific cancers, potentially due to defective IFN response in some cancer cells.
  • Defects in IFN signaling may allow cancer cells to evade growth control.

Purpose of the Study:

  • To investigate if enhancing Type I IFN receptor (IFNAR2c) expression can restore cancer cell sensitivity to IFN's antiproliferative effects.
  • To evaluate the impact of increased IFNAR2c expression on IFN-induced apoptosis and in vivo tumor growth.

Main Methods:

  • Transfection of three human cancer cell lines to enhance IFNAR2c expression.
  • Assessment of IFN dose-response curves for cell death.
  • Measurement of apoptosis via DNA fragmentation and Caspase 3 activation.
  • In vivo studies using a xenograft tumor model with IFNAR2c-transfected cells.

Main Results:

  • Enhanced IFNAR2c expression significantly increased cancer cell sensitivity to IFN's antiproliferative effects.
  • Lower IFN concentrations were required to induce maximum cell death in transfected cells.
  • Increased apoptosis and Caspase 3 activation were observed in IFNAR2c-expressing cells.
  • Systemic Betaseron treatment was more effective in reducing tumor burden in vivo for tumors derived from IFNAR2c-transfected cells.

Conclusions:

  • Specific regulation of IFN receptor expression is crucial for determining the clinical effectiveness of IFN-based cancer therapeutics.
  • Restoring or enhancing IFNAR2c expression can overcome resistance to IFN-dependent growth control in cancer cells.
  • This approach holds potential for improving outcomes in IFN-based cancer therapy.

More Related Videos

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses10:10

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Published on: November 16, 2016

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...